St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

STJ 67.03 -0.03 (-0.04%)
price chart
Insider Selling: St. Jude Medical VP Sells 5997 Shares of Stock (STJ)
Analysts at JPMorgan Chase & Co. reiterated an �overweight� rating on shares of St. Jude Medical in a research note on Thursday, July 17th.
Related articles »  
September 20th Options Now Available For St. Jude Medical (STJ)
Investors in St. Jude Medical, Inc. (NYSE: STJ) saw new options begin trading today, for the September 20th expiration.
Related articles »  
Layoffs at St. Jude Medical
St. Jude Medical Inc. will lay off up to 270 employees at its Sylmar heart-device manufacturing facility following a corporate restructuring.
St. Jude Medical Receives �Overweight� Rating from JPMorgan Chase & Co. (STJ)
St. Jude Medical, Inc. logo St. Jude Medical (NYSE:STJ)'s stock had its �overweight� rating restated by investment analysts at JPMorgan Chase & Co.
St. Jude Medical Beats on Q2 Earnings, Upgrades Outlook - Analyst Blog  NASDAQ
St. Jude not keen to join inversion deal craze  Chicago Tribune (blog)
Related articles »  
Versatile News at Street: McDonald's (NYSE:MCD), St. Jude Medical (NYSE:STJ ...
St. Jude Medical, Inc. (NYSE:STJ) [Trend Analysis] reported that CE Mark authorization and first use of the FlexAbility Ablation Catheter, a novel ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias.
St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility ...
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval and first use of the FlexAbility(TM) Ablation Catheter, a novel ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias.
St Jude Medical's FlexAbility Ablation Catheter launches in Europe  Zenopa
Related articles »  
Recent Investment Analysts' Ratings Updates for St. Jude Medical (STJ)
St. Jude Medical had its �sell� rating reaffirmed by analysts at Citigroup Inc.. They now have a $57.00 price target on the stock, up previously from $53.00.
St. Jude Medical to Acquire Chronic Pain Solutions Maker - Analyst Blog
St. Jude Medical Inc. ( STJ ) revealed that it will acquire privately held chronic pain solutions maker NeuroTherm for cash payment of roughly $200 million.
St. Jude Medical (STJ) to Acquire NeuroTherm in $200M Deal  StreetInsider.com (subscription)
St. Jude Medical deal adds to pain management line  Minneapolis Star Tribune
Related articles »  
St. Jude Medical Announces Definitive Agreement to Acquire NeuroTherm
WILMINGTON, Mass., Jul 14, 2014 (BUSINESS WIRE) -- St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced that it has signed a definitive agreement to acquire privately held NeuroTherm, Inc., a manufacturer of ...
St. Jude Medical Receives Average Recommendation of �Hold� from Brokerages ...
St. Jude Medical logo Shares of St. Jude Medical (NYSE:STJ) have earned an average rating of �Hold� from the twenty-two brokerages that are presently covering the company, American Banking News reports. Two investment analysts have rated the stock ...